News archive

July 2021

HIV-1 and TB coinfection skews the SARS-CoV-2 T cell response - Thu, 07/01/2021 - 10:30

June 2021

WNT7A: The new marker for resting T cells - Tue, 06/29/2021 - 10:00
Does serial administration of HIV-specific VRC01 bnAbs prevent HIV acquisition? - Mon, 06/28/2021 - 11:00
An update on the Shock and kill HIV cure strategy - Thu, 06/24/2021 - 15:45
IUIS-Immunopaedia-Frontiers Webinar: Clinical representation of hyperinflammation - Tue, 06/22/2021 - 16:15
IUIS-Immunopaedia-Frontiers webinar: In-depth characterisation of immune cells in Ebola virus - Thu, 06/17/2021 - 16:45
BCG reduces all-cause infectious diseases in the first 6 weeks of life in infants! - Tue, 06/15/2021 - 15:30
IUIS-Immunopaedia-Frontiers webinar: Getting to the “bottom” of arthritis - Thu, 06/10/2021 - 10:45

May 2021

Exploring characteristics of COVID-19 to guide public health policies & therapeutic interventions - Tue, 05/11/2021 - 11:00
C5a-C5aR1 axis plays a role in cobra venom immunopathology - Fri, 05/07/2021 - 13:00
Antibody response to vaccination post-COVID-19 infection - Tue, 05/04/2021 - 09:45

April 2021

Aged Neutrophils support tumor metastasis - Thu, 04/29/2021 - 10:45
P.falciparum secretes extracellular vesicles with functional 20S proteasomes to prime RBCs for parasite invasion - Wed, 04/28/2021 - 08:45
Pregnant women show elevated levels of anti-inflammatory glycosylation patterns of IgG antibodies - Wed, 04/28/2021 - 08:45
First report on Effectiveness of HPV Vaccination in LMICs – Rwanda and Bhutan - Wed, 04/21/2021 - 09:00
Does ACE2 expression & cytotoxic lymphocyte levels indicate a risk factor for COVID-19? - Fri, 04/16/2021 - 15:15
Immunopathogenesis of Autoimmune Hepatitis - Wed, 04/14/2021 - 09:30
B1.1.135 (501Y.V2) induces cross-reactive Ab responses to other SARS-CoV-2 variants - Fri, 04/09/2021 - 14:15
IUIS-Immunopaedia-Frontiers Webinar on Immunology taught by P. falciparum - Fri, 04/09/2021 - 14:15
Is tumour circulating DNA a better tool for cancer diagnostic and prognostic than immunological biomarkers? - Thu, 04/01/2021 - 13:30

March 2021

HPV & HIV infection are associated with high levels of activated CD4 T cells in the cervix uteri - Tue, 03/30/2021 - 14:30
Predicting tissue graft outcomes using immune markers - Mon, 03/29/2021 - 12:00
JoAnne Flynn: BCG IV vaccination induces sterilising M.tb immunity - Thu, 03/25/2021 - 13:30
Flynn Webinar: Immune features associated natural infection - Tue, 03/16/2021 - 14:15
BCG vaccination reduces infection in the elderly - Mon, 03/15/2021 - 14:15
Exploratory study investigates the relationship between recent vaccinations and SARS-CoV-2 infection rates - Fri, 03/12/2021 - 11:30
Statins: improved survival rates and reduced mortality rate in COVID-19 patients - Wed, 03/10/2021 - 14:30
Myeloid-derived suppressor cells: drivers of severe COVID-19 disease? - Mon, 03/08/2021 - 15:15
The path to sterilizing immunity against tuberculosis - Wed, 03/03/2021 - 11:15
IUIS Webinar on harnessing innate immunity from cancer therapy to COVID-19 - Wed, 03/03/2021 - 11:15

February 2021

Uterine NK cell differentiation during the menstrual cycle and pregnancy - Fri, 02/26/2021 - 14:15
Global ImmunoTalk on dissecting the interaction of parasites with the immune system - Wed, 02/24/2021 - 15:15
Researchers may have found a way to “cure” cat allergies? - Mon, 02/22/2021 - 13:30
The antibody response to SARS-CoV-2 501Y.v2 variant and vaccine implications - Fri, 02/19/2021 - 16:30
Do mutations in SARS-CoV-2 variants reduce the functional activity of mRNA-vaccine elicited Abs? - Wed, 02/17/2021 - 13:45
IUIS/Immunopaedia-Frontiers Webinar on Immunoregulation and the tumor microenvironment - Mon, 02/15/2021 - 14:00
Are current putative COVID-19 vaccines effective against the B.1.351 variants? - Tue, 02/09/2021 - 15:45
Phase 2a trial provides evidence for potential pancreatic cancer immunotherapy - Mon, 02/08/2021 - 15:00
COVID-19 is associated with increased MAIT cell activation and cytotoxicity - Wed, 02/03/2021 - 16:15
Saliva viral load could be a potential correlate of severe COVID-19 - Tue, 02/02/2021 - 15:15

January 2021

Mutations in SARS-Cov-2 B.1.351 variant reduces vaccine induced Ab neutralisation - Thu, 01/28/2021 - 11:30
Immuno-metabolism and cognitive decline - Mon, 01/25/2021 - 18:00
Ad26.COV2.S is safe and immunogenic - Fri, 01/22/2021 - 17:00
SARS-CoV-2-specific Memory B cells persist up to 8 months post infection - Tue, 01/19/2021 - 16:30
Gene editing as a potential sickle cell disease immunotherapy - Tue, 01/19/2021 - 11:45
Not all SARS-CoV-2 mutations lead to reduced antibody neutralisation capacity - Thu, 01/14/2021 - 13:15
Development of a serological diagnostic of Johne’s Disease - Tue, 01/12/2021 - 13:45
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine - Wed, 01/06/2021 - 14:15

December 2020

Lack of interference by type I interferons leads to severe COVID-19 - Thu, 12/17/2020 - 11:45
BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccine efficacy results - Mon, 12/14/2020 - 11:00